Lv4
490 积分 2024-03-01 加入
Microbiomes in health, diseases and therapeutics
9天前
已完结
A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in healthy adults
2个月前
已关闭
Clostridioides difficile infections; new treatments and future perspectives
2个月前
已关闭
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile)
2个月前
已完结
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial
2个月前
已完结
The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection
2个月前
已关闭
Butyrate’s role in human health and the current progress towards its clinical application to treat gastrointestinal disease
2个月前
已完结
A new perspective in the prevention and treatment of antitumor therapy-related cardiotoxicity: Intestinal microecology
2个月前
已关闭
The potential role of prebiotics, probiotics, and synbiotics in adjuvant cancer therapy especially colorectal cancer
2个月前
已完结
How bile acids and the microbiota interact to shape host immunity
2个月前
已完结
皖公网安备34019202002308
